LifeStance Health Group, Inc. Repayments of Long-Term Debt
LifeStance Health Group, Inc. (LFST) reported Repayments of Long-Term Debt of $7.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-06
- LifeStance Health Group, Inc. repayments of long-term debt for the quarter ending 2026-06-30 was $7.25M, a 300.11% increase year-over-year.
- LifeStance Health Group, Inc. repayments of long-term debt for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- LifeStance Health Group, Inc. repayments of long-term debt for the quarter ending 2025-12-31 was $1.81M, a 99.37% decline year-over-year.
- LifeStance Health Group, Inc. repayments of long-term debt for the quarter ending 2025-09-30 was $1.81M, a 148.02% increase year-over-year.
- LifeStance Health Group, Inc. repayments of long-term debt for fiscal 2025 was $7.25M, a 97.50% decline from fiscal 2024.
- LifeStance Health Group, Inc. repayments of long-term debt for fiscal 2024 was $289.49M, a 11620.40% increase from fiscal 2023.
- LifeStance Health Group, Inc. repayments of long-term debt for fiscal 2023 was $2.47M, a 98.68% decline from fiscal 2022.
- LifeStance Health Group, Inc. repayments of long-term debt for fiscal 2022 was $187.77M, a 39.70% decline from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 4 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $7.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.25M 10-Q · filed 2026-08-06 | $9.06M derived: sum of 3 quarters · filed 2026-08-06 | $10.88M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $1.81M derived: sum of 2 quarters · filed 2026-05-07 | $3.63M derived: sum of 3 quarters · filed 2026-05-07 | $5.44M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.63M derived: sum of 2 quarters · filed 2026-02-25 | $5.44M derived: sum of 3 quarters · filed 2026-08-06 | $7.25M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.63M derived: sum of 2 quarters · filed 2026-08-06 | $5.44M 10-Q · filed 2025-11-06 | $292.74M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.63M 10-Q · filed 2026-08-06 | $290.93M derived: sum of 3 quarters · filed 2026-08-06 | $291.66M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.81M 10-Q · filed 2026-05-07 | $289.11M derived: sum of 2 quarters · filed 2026-05-07 | $289.84M derived: sum of 3 quarters · filed 2026-05-07 | $290.58M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $287.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $288.03M derived: sum of 2 quarters · filed 2026-02-25 | $288.76M derived: sum of 3 quarters · filed 2026-02-25 | $289.49M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.46M derived: sum of 2 quarters · filed 2025-11-06 | $2.19M 10-Q · filed 2025-11-06 | $2.84M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $732.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.46M 10-Q · filed 2025-08-07 | $2.11M derived: sum of 3 quarters · filed 2026-02-25 | $2.76M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $731.00K 10-Q · filed 2025-05-07 | $1.38M derived: sum of 2 quarters · filed 2026-02-25 | $2.03M derived: sum of 3 quarters · filed 2026-02-25 | $2.62M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $649.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.30M derived: sum of 2 quarters · filed 2026-02-25 | $1.88M derived: sum of 3 quarters · filed 2026-02-25 | $2.47M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $648.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.24M derived: sum of 2 quarters · filed 2024-11-07 | $1.82M 10-Q · filed 2024-11-07 | $8.36M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $587.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.17M 10-Q · filed 2024-08-08 | $7.71M derived: sum of 3 quarters · filed 2025-02-27 | $7.71M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $586.00K 10-Q · filed 2024-05-09 | $7.12M derived: sum of 2 quarters · filed 2025-02-27 | $7.12M derived: sum of 3 quarters · filed 2025-02-27 | $188.02M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.54M derived: sum of 2 quarters · filed 2025-02-27 | $187.44M derived: sum of 3 quarters · filed 2025-02-27 | $187.77M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $180.90M derived: sum of 2 quarters · filed 2023-11-08 | $181.23M 10-Q · filed 2023-11-08 | $181.56M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $180.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $181.23M 10-Q · filed 2023-08-09 | $181.56M derived: sum of 3 quarters · filed 2024-02-28 | $181.89M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $331.00K 10-Q · filed 2023-05-10 | $661.00K derived: sum of 2 quarters · filed 2024-02-28 | $992.00K derived: sum of 3 quarters · filed 2024-02-28 | $310.94M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $661.00K derived: sum of 2 quarters · filed 2024-02-28 | $310.61M derived: sum of 3 quarters · filed 2024-02-28 | $311.39M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $331.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $310.27M derived: sum of 2 quarters · filed 2022-11-09 | $311.06M 10-Q · filed 2022-11-09 | $328.71M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-06-30 | $309.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $310.73M 10-Q · filed 2022-08-10 | $328.38M derived: sum of 3 quarters · filed 2023-03-09 | $328.97M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-03-31 | $785.00K 10-Q · filed 2022-05-11 | $18.44M derived: sum of 2 quarters · filed 2023-03-09 | $19.03M derived: sum of 3 quarters · filed 2023-03-09 | $157.57M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2020-12-31 | $17.66M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $18.25M derived: sum of 2 quarters · filed 2023-03-09 | $156.78M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $590.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-10 | $139.13M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $138.54M 10-Q · filed 2021-08-12 | ||||
| 2020-05-14 | $18.22M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $488.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |